Agenda

2020 Agenda is now available!

The Cell & Gene Meeting on the Med features expert-led panels, in-depth keynote speeches, interactive fireside chats, and 50+ presentations by leading publicly traded and privately held companies from around the globe.

 

 

 

 

7:45am – 8:45am | REGISTRATION

8:45am | GENERAL SESSION AND PARTNERING OPENS

8:45am – 9:00am

WELCOME AND STATE OF THE INDUSTRY REMARKS {Gaudi 3}

Speaker:

Janet Lynch Lambert, CEO, Alliance for Regenerative Medicine (ARM)

9:00am – 9:45am

KEYNOTE ADDRESS & FIRESIDE CHAT {Gaudi 3}

Speaker:

Guido Rasi, M.D., Director General, European Medicines Agency (EMA)

Fireside Chat With:

Miguel Forte, M.D., Ph.D., CEO of Bone Therapeutics

9:45am – 10:45am

PLENARY SESSION: LESSONS LEARNED FROM COMMERCIAL PIONEERS   {Gaudi 3}

Speakers:

Lisa Deschamps, SVP and Chief Business Officer, AveXis
Alison Finger, Chief Commercial Officer, bluebird bio
Robin Kenselaar, SVP & General Manager EMEA, Orchard Therapeutics

10:45am – 11:15am | MORNING BREAK

11:15am – 12:30pm | CONCURRENT TRACKS

COMPANY PRESENTATIONS {Gaudi 3}

11:15am – 11:30am
11:30am – 11:45am
11:45am – 12:00pm
12:00pm – 12:15pm
12:15pm – 12:30pm

COMPANY PRESENTATIONS {Gaudi 3}

11:15am – 11:30am
11:30am – 11:45am
11:45am – 12:00pm
12:00pm – 12:15pm
12:15pm – 12:30pm

12:30pm – 1:45pm | LUNCH
Sponsored by Covance

1:45pm – 3:30pm | CONCURRENT TRACKS

PANEL: HOSPITAL EXEMPTION: IMPLICATIONS FOR PATIENTS AND INNOVATION  {Gaudi 3}
1:45pm – 2:45pm

Chair:
Anthony Davies, Ph.D., Founder & CEO, Dark Horse Consulting
Speakers:
Josep M. Canals, Ph.D., University of Barcelona and member of League of European Research Universities
Antonella Cardone, Director, European Cancer Patient Coalition
Álvaro Urbano-Ispizua, M.D., Haematologist, Hospital Clinic, Barcelona

COMPANY PRESENTATIONS {Gaudi 2}

1:45pm – 2:00pm
2:00pm – 2:15pm
2:15pm – 2:30pm
2:30pm – 2:45pm

COMPANY PRESENTATIONS {Gaudi 3}

2:45pm – 3:00pm
3:00pm – 3:15pm
3:15pm – 3:30pm

COMPANY PRESENTATIONS {Gaudi 2}

2:45pm – 3:00pm
3:00pm – 3:15pm
3:15pm – 3:30pm

3:30pm – 4:00pm | AFTERNOON BREAK

4:00pm – 5:00pm | CONCURRENT TRACKS

PANEL: CELL AND GENE THERAPIES FOR CHRONIC CONDITIONS {Gaudi 3}
4:00pm – 5:00pm

Speakers:
Pavan Cheruvu, M.D., CEO, Axovant Gene Therapies
Jane Lebkowski, Ph.D., President of R&D, Regenerative Patch Technologies
Emile Nuwaysir, Ph.D., President and CEO, BlueRock Therapeutics
Philip Toleikis, Ph.D., President & CEO, Sernova

COMPANY PRESENTATIONS {Gaudi 2}

4:00pm – 4:15pm
4:15pm – 4:30pm
4:30pm – 4:45pm
4:45pm – 5:00pm

5:00pm | PARTNERING CLOSES

6:00pm – 9:00pm | NETWORKING BASH

 

 

 

 

7:30am – 8:30am | REGISTRATION

8:30am | GENERAL SESSION AND PARTNERING OPENS

8:30am – 8:45am

WELCOME REMARKS {Gaudi 3}

Speaker:

Matthew Patterson, Strategic Advisor, Audentes Therapeutics, An Astellas Company; Chairman, Alliance for Regenerative Medicine (ARM)

8:45am – 10:45am | CONCURRENT TRACKS

PANEL: THE NEXT WAVE OF COMMERCIAL DEVELOPMENT   {Gaudi 3}
8:45am – 9:45am

Speakers:
Jeff Ajer, Executive Vice President, Chief Commercial Officer, BioMarin
Bernard Gilly, Ph.D., CEO & Co-Founder, GenSight
Rachelle Jacques, CEO, Enzyvant
Christopher Vann, SVP & Chief Operating Officer, Autolus Therapeutics

COMPANY PRESENTATIONS {Gaudi 2}

8:45am – 9:00am
9:00am – 9:15am
9:15am – 9:30am
9:30am – 9:45am

SPOTLIGHT SESSION: PATIENT-FOCUSED TOPIC {Gaudi 3}
9:45am – 10:15am

COMPANY PRESENTATIONS {Gaudi 2}

9:45am – 10:00am
10:00am – 10:15am

FIRESIDE CHAT: DISCUSSION WITH GERMAN MARKET ACCESS POLICYMAKER {Gaudi 3}
10:15am – 10:45am

COMPANY PRESENTATIONS {Gaudi 2}

10:15am – 10:30am
10:30am – 10:45am

10:45am – 11:15am | MORNING BREAK

11:15am – 12:30pm | CONCURRENT TRACKS

COMPANY PRESENTATIONS {Gaudi 3}

11:15am – 11:30am
11:30am – 11:45am
11:45am – 12:00pm
12:00pm – 12:15pm
12:15pm – 12:30pm

COMPANY PRESENTATIONS {Gaudi 2}

11:15am – 11:30am
11:30am – 11:45am
11:45am – 12:00pm
12:00pm – 12:15pm
12:15pm – 12:30pm

12:30pm – 1:45pm | LUNCH
Sponsored by Polyplus-Transfection

1:45pm – 3:00pm | CONCURRENT TRACKS

COMPANY PRESENTATIONS {Gaudi 3}

1:45pm – 2:00pm
2:00pm – 2:15pm

COMPANY PRESENTATIONS {Gaudi 2}

1:45pm – 2:00pm
2:00pm – 2:15pm

PANEL: DISRUPTIVE TECHNOLOGIES THAT WILL CHANGE THE CELL THERAPY LANDSCAPE  {Gaudi 3}
2:15pm – 3:00pm

Speaker:
Friedrich Finckenstein, M.D., Chief Medical Officer, Iovance Biotherapeutics
Paul Hastings, CEO, Nkarta Therapeutics

COMPANY PRESENTATIONS {Gaudi 2}

2:15pm – 2:30pm
2:30pm – 2:45pm
2:45pm – 3:00pm

3:00pm – 3:30pm | AFTERNOON BREAK

3:30pm – 5:00pm | CONCURRENT TRACKS

COMPANY PRESENTATIONS {Gaudi 3}

3:30pm – 3:45pm
3:45pm – 4:00pm

COMPANY PRESENTATIONS {Gaudi 2}

4:00pm – 5:00pm

PANEL CLOSING REMARKS: THE STATE OF MONEY  {Gaudi 3}

Chair:

Matthew Durdy, Chief Executive of the Cell and Gene Therapy Catapult

Speaker:

Dmitry Kuzmin, Ph.D., Managing Partner, 4BIO Capital

5:00pm | PARTNERING CLOSES

6:00pm – 8:00pm | WINE TASTING AND RECEPTION 
Sponsored by Dark Horse Consulting

 

 

 

 

8:00am – 11:00am | ARM EU COMMITTEE MEETINGS
Open to ARM Members Only

By using this website you agree to accept our Privacy Policy and Terms & Conditions